MARKET

ENDP

ENDP

Endo Intl
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.12
-0.10
-1.39%
After Hours: 7.16 +0.04 +0.56% 19:07 01/15 EST
OPEN
7.24
PREV CLOSE
7.22
HIGH
7.27
LOW
7.01
VOLUME
2.75M
TURNOVER
--
52 WEEK HIGH
8.29
52 WEEK LOW
2.080
MARKET CAP
1.64B
P/E (TTM)
-15.2299
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Post-Operative Pain Management Market Overview: Type and Applications, Trends, Industry Analysis & Forecast, 2018-2023
Heraldkeepers · 5d ago
Here's Why Momentum Investors Will Love Endo International (ENDP)
Does Endo International (ENDP) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks · 6d ago
Here's Why Momentum Investors Will Love Endo International (ENDP)
Zacks.com · 6d ago
Voltaren Market 2021 CAGR Status, Share, Top Manufacturers, Expected to Demand Drivers, Size and Growth Factor and Forecast 2026
Jan 11, 2021 (The Expresswire) -- Global “Voltaren Market” statistical inspecting report is a guide, which serves current and Voltaren future specialized and...
The Express Wire · 6d ago
Global Medical Anesthesia Agent Market 2020 to 2025 Product, Distribution Channel, Region, Forecast and Opportunities during Ongoing COVID-19 Pandemic
CDN Newswire · 6d ago
Global Pain Management Therapeutics Market Outlook - 2021, Segment Analysis, Top Key Players, Growth Rate, Competitive Landscape, Development Status, Business Strategies, Forecast till 2026
The Express Wire · 6d ago
Opioids Agonist Drugs Market Size 2020 by Cost Analysis, Revenue, Gross Margin Analysis, Types, Application and Forecast to 2024
Jan 11, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Opioid drugs act on the opioid receptors...
The Express Wire · 6d ago
Global Medical Anesthesia Agent Market 2020 Industrial Trends, Consumption Volume, Key Tactics and Competitive Strategies by 2025
Jan 10, 2021 (CDN Newswire via Comtex) -- Global Medical Anesthesia Agent Market 2020 by Manufacturers, Type and Application, Forecast to 2025 interprets...
CDN Newswire · 01/10 21:33
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ENDP. Analyze the recent business situations of Endo Intl through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 15 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ENDP stock price target is 6.27 with a high estimate of 12.00 and a low estimate of 3.000.
EPS
Institutional Holdings
Institutions: 301
Institutional Holdings: 196.74M
% Owned: 85.43%
Shares Outstanding: 230.29M
TypeInstitutionsShares
Increased
64
16.13M
New
57
2.44M
Decreased
53
18.45M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.43%
Pharmaceuticals & Medical Research
+0.21%
Key Executives
Chairman/Director
Paul Campanelli
President/Chief Executive Officer/Director
Blaise Coleman
Chief Operating Officer/Executive Vice President
Terrance Coughlin
Executive Vice President
Patrick Barry
Executive Vice President
Domenico Ciarico
Executive Vice President
Domenic Ciarico
Executive Vice President
Rahul Garella
Executive Vice President
Matthew Maletta
Senior Vice President/Chief Accounting Officer/Controller
Jack Boyle
Independent Director
Mark Barberio
Independent Director
Shane Cooke
Independent Director
Nancy Hutson
Independent Director
Michael Hyatt
Independent Director
Roger Kimmel
Independent Director
William Montague
Independent Director
M. Christine Smith
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About ENDP
Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The Company's generics portfolio has a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and world markets.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Endo International PLC stock information, including NASDAQ:ENDP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENDP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ENDP stock methods without spending real money on the virtual paper trading platform.